CH2900010

フォリン酸 カルシウム塩

USP, Ph. Eur.

• 別名: カルシウムホリナート
• 実験式（ヒル表記法）: C₂₀H₂₁CaN₇O₇
• CAS Number: 1492-18-8
• 分子量: 511.50
• MDL番号: MFCD00006704
• UNSPSCコード: 41116107

特性

• 由来生物: synthetic
• 品質水準: 600
• グレード: GMO free; GMP; Halal; Kosher
• 認証: Ph. Eur.; USP
• フォーム: powder
• アプリケーション: liquid formulation; pharmaceutical
• 保管温度: 2-8°C
• SMILES記法: [Ca+2].[nH]1c2c([c](nc1N)=O)N(C(CN2)CNc3ccc(cc3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])C=O
• InChI: 1S/C20H23N7O7.Ca/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30;/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32);/q;+2/p-2/t12?,13-;/m0./s1
• InChI Key: KVUAALJSMIVURS-ZEDZUCNESA-L

詳細

詳細

We provide industry-leading production know-how and comprehensive regulatory support for high-quality APIs, backed by nearly 200 years of experience. From a complete portfolio of innovative folates to custom synthesis, our customized and scalable solutions meet your specific production needs. Our SAFC^® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

アプリケーション

Calcium Folinate Hydrate amorphous has three main clinical applications:
1) First line treatment for colorectal cancer: In combination with the anticancer drug 5-fluorouracil (5-FU), Irinotecan, Cisplatin or Oxaliplatin, and its derivatives. Calcium Folinate is a modulator of 5-FU and enhances its efficacy in cancer chemotherapy.
2) Treatment of certain neoplastic diseases, severe psoriasis, and adult rheumatoid arthritis as a rescue therapy to reduce the toxic side effects of intermediate or high doses of methotrexate.
3) Treatment of anemia caused by folate deficiency.

包装

Customized packaging possible

法的情報

SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

安全性情報

• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 1
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable